Sort
15,842 grants matching “pancreatic cancer”
Molecular Mechanisms of Adverse Metabolic Events by Asparaginase.
$397,803Tracy G. Anthony · Rutgers, The State Univ Of N.J. · R01 · FY2012 · HD
Consortium for the Study of Pancreatitis: Pittsburgh Clinical Center
$397,778Dhiraj Yadav · University Of Pittsburgh At Pittsburgh · U01 · FY2019 · DK
Targeting HuR to improve a synthetic lethal therapy for pancreatic cancer
$397,605Jonathan Brody · Thomas Jefferson University · R01 · FY2017 · CA
Role of acetyl-CoA in linking cancer cell metabolism and epigenetics
$397,600Kathryn Elaine Wellen · University Of Pennsylvania · R01 · FY2020 · CA
FoxO signaling and skeletal muscle atrophy
$397,595Andrew Robert Judge · University Of Florida · R01 · FY2017 · AR
Key factors in human ribosome biogenesis
$397,570Susan J Baserga · Yale University · R01 · FY2016 · GM
Key factors in human ribosome biogenesis
$397,509Susan J Baserga · Yale University · R01 · FY2017 · GM
Role of pH-mediated metabolic reprogramming in β cell failure in Type 2 Diabetes Mellitus
$397,500Aleksey V Matveyenko · Mayo Clinic Rochester · R01 · FY2021 · DK
Role of pH-mediated metabolic reprogramming in β cell failure in Type 2 Diabetes Mellitus
$397,500Aleksey V Matveyenko · Mayo Clinic Rochester · R01 · FY2023 · DK
The Exocrine and Endocrine Pancreas in Type 2 Diabetes, Pancreatitis and Cancer
$397,500Suresh T. Chari · Mayo Clinic Rochester · U01 · FY2015 · DK
Role of pH-mediated metabolic reprogramming in β cell failure in Type 2 Diabetes Mellitus
$397,500Aleksey V Matveyenko · Mayo Clinic Rochester · R01 · FY2022 · DK
Key factors in human ribosome biogenesis
$397,447Susan J Baserga · Yale University · R01 · FY2018 · GM
MyD88 fusion protein with antigen specific T Cell therapy for enhanced response in solid tumors
$397,422Samantha Dunmire · Luminary Therapeutics, Inc. · R43 · FY2020 · CA
The role of entosis in human cancers
$397,329Michael H. Overholtzer · Sloan-Kettering Inst Can Research · R01 · FY2017 · CA
Sex-dependent rescue of cancer cachexia
$397,258Erin E Talbert · University Of Iowa · R21 · FY2021 · CA
Exploiting Caveolae-Dependent Albumin Endocytosis to Optimize Therapy in Pancreatic Cancer
$397,192Terence Marques Williams · Ohio State University · R01 · FY2017 · CA
siRNA Protection of Islet Grafts in Baboons
$397,132Anna Moore · Massachusetts General Hospital · R01 · FY2017 · DK
A Clinical Center to Study Immunological and Hormonal Biomarkers for the Diagnosis, Prediction and Treatment of Chronic Pancreatitis and its associated development to Diabetes and Pancreas Cancer
$397,128Walter Gwang-Up Park · Stanford University · U01 · FY2019 · DK
Neutralizing Stromal NetrinG1 to Intercept Pancreatic Cancer
$397,088Edna Cukierman · Research Inst Of Fox Chase Can Ctr · U54 · FY2024 · CA
Antibody-dual drug conjugates for eradicating triple-negative breast cancer with heterogeneity
$397,082Kyoji Tsuchikama · University Of Texas Hlth Sci Ctr Houston · R01 · FY2024 · CA
AKT2 Function and Oncogenic Activity
$396,934Fox Chase Cancer Center · R01 · FY2003 · CA
Project 1: Elucidating the genetics and cell of origin of pancreatic cancer initiation
$396,921Laura D Attardi · Stanford University · P01 · FY2024 · CA
Comprehensive genetic dissection of druggable KRAS targets
$396,907Steven D Leach · Dartmouth College · R01 · FY2017 · CA
MOUSE MODELS FOR HUMAN CANCER
$396,760University Of Wisconsin Madison · U01 · FY2002 · CA
Regulation of KRAS plasma membrane targeting by defined glycosphingolipids.
$396,725John F Hancock · University Of Texas Hlth Sci Ctr Houston · R01 · FY2024 · GM